Imaging SERT Availability in a Rat Model of L-DOPA-Induced Dyskinesia.

Molecular Imaging and Biology : MIB : the Official Publication of the Academy of Molecular Imaging
Michael WalkerKristina Herfert

Abstract

The development of L-DOPA-induced dyskinesia (LID) is one of the most severe side effects of chronic L-DOPA treatment in Parkinson's disease patients. [11C]DASB positron emission tomography (PET) provides a prominent tool to visualize and quantify serotonin transporter (SERT) pathology in vivo in patients and in animal models. To evaluate the effect of chronic L-DOPA treatment on SERT availability in an animal model of LID, we performed a longitudinal PET study. Rats received a unilateral 6-hydroxydopamine (6-OHDA) lesion, and striatal and extrastriatal SERT expression levels were studied with [11C]DASB, a marker of SERT availability, before and after daily treatment with L-DOPA. Dyskinesias were evaluated at different time points over a period of 21 days. [11C]DASB binding was found to be decreased after 6-OHDA lesions in the striatum, cortex, and hippocampus 5 weeks after 6-OHDA injection in the lesioned hemisphere of the rat brain. Chronic L-DOPA priming resulted in a relative preservation of SERT availability in the lesioned and healthy hemisphere compared to baseline measurements. Our longitudinal PET data support a preservation of SERT availability after the induction of L-DOPA-induced dyskinesia, which is in line with pr...Continue Reading

References

Dec 1, 1968·European Journal of Pharmacology·U Ungerstedt
Dec 1, 1996·NeuroImage·A A Lammertsma, S P Hume
Oct 29, 2000·Trends in Neurosciences·J A ObesoJ G Nutt
Nov 1, 2000·Nuclear Medicine and Biology·A A WilsonS Houle
Jun 8, 2001·Movement Disorders : Official Journal of the Movement Disorder Society·J E Ahlskog, M D Muenter
Apr 23, 2002·Journal of Neurology·Anette SchragNiall Quinn
Dec 7, 2002·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·Yanjun Wu, Richard E Carson
Feb 26, 2003·Neurology·M DoderUNKNOWN 11C-WAY 100635 PET study
Sep 18, 2004·Trends in Neurosciences·Mark P MattsonBronwen Martin
Apr 12, 2005·Movement Disorders : Official Journal of the Movement Disorder Society·Joseph Jankovic
Mar 8, 2006·Journal of Neuroscience Methods·Wynne K SchifferStephen L Dewey
Sep 1, 2006·Journal of Neurochemistry·M Angela Cenci, Martin Lundblad
Oct 4, 2006·Nature Reviews. Drug Discovery·Anthony H V SchapiraGiora Davidai
Apr 25, 2007·Brain : a Journal of Neurology·Manolo CartaAnders Björklund
Jun 29, 2007·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Emanuela SantiniGilberto Fisone
Jul 27, 2007·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Thomas CarlssonDeniz Kirik
Feb 19, 2008·The FEBS Journal·Emanuela SantiniGilberto Fisone
Apr 23, 2008·Current Protocols in Neuroscience·M Angela Cenci, Martin Lundblad
Jun 27, 2008·Parkinsonism & Related Disorders·Manolo CartaAnders Björklund
Aug 21, 2008·Nature Reviews. Neuroscience·Peter Jenner
Sep 11, 2008·Movement Disorders : Official Journal of the Movement Disorder Society·Jose A ObesoManuel Rodriguez
Mar 3, 2009·Proceedings of the National Academy of Sciences of the United States of America·Antonio Pisani, Jie Shen
Aug 27, 2010·Nature·Alison Abbott
Oct 1, 2010·Annals of Neurology·Daniella RylanderM Angela Cenci
Jun 1, 2011·Movement Disorders : Official Journal of the Movement Disorder Society·Olivier RascolWerner Poewe
Jun 18, 2011·Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine·Kristina FischerBernd J Pichler
Nov 29, 2011·Central Nervous System Agents in Medicinal Chemistry·Sylvia NavaillesPhilippe De Deurwaerdère
Nov 7, 2012·Cell Transplantation·Shao-Ju WengKuo-Hsing Ma
Jan 16, 2013·Pharmacological Reviews·Philippe HuotJonathan M Brotchie
Feb 18, 2014·The Journal of Clinical Investigation·Marios PolitisPaola Piccini

❮ Previous
Next ❯

Citations

Mar 10, 2021·British Journal of Pharmacology·Sergio Vegas-SuárezLuisa Ugedo

❮ Previous
Next ❯

Related Concepts

Related Feeds

Basal Ganglia

Basal Ganglia are a group of subcortical nuclei in the brain associated with control of voluntary motor movements, procedural and habit learning, emotion, and cognition. Here is the latest research.